Swiss Re

🔬 Overdiagnosis highlights a potential downside of increasingly sensitive cancer detection. Around 76% of thyroid cancer cases globally are linked to overdiagnosis, underscoring the need to balance early detection with unnecessary intervention. ow.ly/nxw650Z3fZw

🔬 Early detection is transforming cancer outcomes. New tests, biomarkers and AI are opening possibilities for earlier diagnosis and improving survival. Cancer risk is evolving with higher incidence and more complex claims. Learn more: ow.ly/uLvi50Z15ak

Why are disaster losses rising? Stronger storms are only part of the story. Exposure expansion drives over 80 percent of the increase in insured nat cat losses, which have grown 5 to 7 percent per year after inflation. Explore the latest sigma insights: ow.ly/bo8b50Ywenw

🔬 Cancer is more frequently diagnosed, yet more survivable than before. Earlier detection and better diagnostics are improving survival. For insurers, this means a fundamental shift with higher incidence, earlier diagnosis and longer duration risk. 👉 ow.ly/t4Zy50YXIVz

Swiss Re CEO Andreas Berger talks about Swiss Re's first quarter 2026 results. Learn more: ow.ly/OHtV50YVVLK

We have published our first quarter 2026 results, reporting a Group net income of USD 1.5 billion. Swiss Re paid out approximately USD 8.9 billion in claims in the first quarter, helping to make our clients and the communities we work with more resilient. ow.ly/XqZF50YVTM8

The global mortality protection gap is at a record high 👉 ow.ly/5fZy50YKgzG Despite improvements in coverage, protection levels remain below where they were a decade ago. Inflation, higher debt and growing income replacement requirements are driving the gap.

Swiss Re shareholders approved all proposals at today’s AGM, including a dividend of USD 8.00 per share and the election of Jean-Jacques Henchoz to the Board of Directors. Read more: ow.ly/OkyY50YH7FM

As populations age, cancer cases in older adults will surge, even as survival improves. More people are living longer with ongoing health needs. For insurers, this reshapes mortality and morbidity. Our latest publication explores the implications 🔗 ow.ly/nvlK50YsIYa

As we mark #WorldHealthDay, it’s worth recognising the role of behaviour in health outcomes. 🥗Our UK disability insurance pilot shows a nutrition-first approach can improve metabolic health, support recovery, and enable a return to work. Learn more 👉 ow.ly/Mnj750Yz3e5

Cancer’s age profile is shifting. In many countries, diagnoses before 50 are rising as fast as, or faster than, those among older groups. For insurers, this means longer survivorship, prolonged treatment and evolving morbidity risk. Learn more: ow.ly/nUTu50YsIRY

Cancer diagnoses in people under 50 are rising across countries. Is this just earlier detection or a generational shift in lifetime risk? Metabolic ill health and early-life exposures may be key drivers. Learn more in our cancer epidemiology report ➡️ swissre.com/reinsurance/in…

At Insurtech Insights Europe, Pravina Ladva reflects on what has changed since last year, noting that AI has had a reality check, with the conversation shifting from excitement about what AI can do to a focus on driving value. More about AI at Swiss Re🔗 swissre.com/risk-knowledge…

Why are disaster losses rising? Stronger storms are only part of the story. Exposure expansion drives over 80 percent of the increase in insured nat cat losses, which have grown 5 to 7 percent per year after inflation. Explore the latest sigma insights: ow.ly/bo8b50Ywenw

📊 Our latest #natcat sigma breaks down the events behind the losses, the long-term growth in catastrophe risk, and what it means for resilience and insurance protection. 👉 Read the full report: ow.ly/L3Ko50Ywaym

Cancer is increasingly affecting people under 50, reshaping assumptions about risk. More diagnoses. Fewer deaths. More long-term impact. 📖 Our latest publication explores what this means for mortality and morbidity: ow.ly/T4Vm50YsiFN

Nicotine use has evolved faster than insurance definitions. As smoking declines, vaping, HTPs, nicotine pouches, and cannabis are reshaping risk, yet frameworks still rely on smoker vs non-smoker. An intermediate risk group is emerging. Read more 👉 ow.ly/qHJ250YmnBc

On #WorldObesityDay, the case is clear: 1 in 5 long-term UK disability claims is driven by obesity and metabolic conditions. Our UK pilot shows change is possible through a nutrition-first approach: 5 participants back to work, £790k in reserves released. ow.ly/r8e850YmpLH

Nicotine use isn’t a simple “smoker vs non-smoker” question anymore. Vapes, heated tobacco, pouches and cannabis blur the line, but testing hasn’t caught up. For insurers, more nuanced testing is needed as nicotine products diversify. 👉 ow.ly/cAUi50YlVZu

On #WorldObesityDay, the issue goes beyond public health. 6 in 10 US adults live with chronic conditions, driving ~90% of healthcare spend. Could “eat real food” help bend the cost curve? Read John Schoonbee’s latest blog 👉 ow.ly/PvIK50YoXyp